Bearing in mind the association of collagen-I over-expression with migration, invasion, breast cancer metastasis and poor survival (36), we can hypothesize that collagen-I’s influence on Annexin A2 phosphorylation and the subsequent degradation of fibronectin, may be one of the many ways in which the ECM can promote cancer progression. The gene discussed is FN1; the disease is breast carcinoma.